All posts by: Michael Zand

About Michael Zand

Enpicom Launches With Plan to Build Software Applications for Immunotherapy Market – GenomeWeb

Continue reading

2017-09-13 NEWS

Enpicom Launches With Plan to Build Software Applications for Immunotherapy Market
GenomeWeb
NEW YORK (GenomeWeb) – Dutch bioinformatics software company Enpicom seeks to build a business around ready-to-use software that will initially support target discovery and development in the immunotherapy space, with plans to expand into clinical …

Continue reading

2017-09-13 NEWS

The Pharma Letter (registration)

Alligator Bioscience signs new immunotherapy research collaboration
The Pharma Letter (registration)
Swedish biotech Alligator Bioscience (STO: ATORX) has entered into a research collaboration agreement has been signed with Professor Ignacio Melero of Spain’s Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Spain, …

and more »

Continue reading

2017-09-13 NEWS

CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for …
GlobeNewswire (press release)
SANTA CLARA, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational …

and more »

Continue reading

2017-09-13 NEWS

CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for …
GlobeNewswire (press release)
SANTA CLARA, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational …